The company is substantially boosted the course of the novel solution for cardiac amyloidosis, utilizing the compound. Initial clinical data reveals promising benefits for patients affected by the serious disease. This https://attrcm290304.daneblogger.com/40758469/bridgebio-advances-cardiac-amyloidosis-therapy-through-the-drug